Eli Lilly gets nod to launch weight-loss drug in Hong Kong

This report summarizes recent health news, covering Eli Lilly's Hong Kong approval for its weight-loss drug, a McDonald's E.
Asian shares mostly declined Thursday as investors grappled with uncertainty ahead of the U.S. election next Tuesday. Japan’s ...
Eli Lilly said it sees fiscal year 2024 sales of $45.4 billion—$46 billion, compared to prior guidance of $45.4 billion—$46.6 ...
Eli Lilly (LLY) has reportedly received approval to sell its weight-loss drugs in Hong Kong, according to Bloomberg. Meanwhile, sales of Apple's (AAPL) iPhone 16 are being blocked in Indonesia ...
Volkswagen board preparing $4.3B cost-savings plan: report. McDonald's confirms beef patties not to blame for E. coli ...
U.S. stock indexes edged lower after drops for Eli Lilly and chip companies overshadowed a jump for Google’s parent company.
Morning Brief Hosts Seana Smith and Brad Smith check in on some of Yahoo Finance's top trending tickers: McDonald's (MCD) ...